CATX Perspective Therapeutics, Inc.

AMEX
$0.78

Perspective Therapeutics, Inc. (CATX) Insider Activity

What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.

Insider signal Bearish Selling ran elevated versus CATX's own trailing one-year pace, with 0% of sale value under a prearranged plan.
Cluster activity 5 buyers in the last 30 days 5 buyers in the last 90 days 3 sellers in the last 90 days
Insiders buying
5
9 transactions
Insiders selling
3
7 transactions
Purchases
$163.4K
191,648 shares
Sales
$1.6M
517,889 shares
Net activity
-$1.5M
purchases less sales

How much of that selling was preplanned? 0% planned / 100% discretionary

10b5-1 plan sales $0 0 transactions · 0 shares
Discretionary sales $1.6M 7 transactions · 517,889 shares

Largest single sale: $526.1K.

Where they traded

Buy Sell Dot area is proportional to transaction value.

Last open-market purchase: November 17, 2026 , by Williamson Robert F III .

Recent open-market activity

Date Insider Role Action Shares Price Value Held after
Williamson Robert F III Director Buy 25,000 $0.84 $21.0K 53,473
Morich Frank Director Buy 15,000 $0.94 $14.0K 30,000
Puhlmann Markus Chief Medical Officer Buy 35,000 $0.84 $29.6K 178,542
Williamson Robert F III 2 fills Director Buy 24,898 $0.84 $20.9K 115,271
Woods Lori A Director Buy 23,750 $0.84 $20.0K 28,557
Morich Frank Director Buy 15,000 $1.00 $15.0K 15,000
Spoor Johan M. Chief Executive Officer Buy 47,000 $0.81 $37.9K 106,383
Puhlmann Markus Chief Medical Officer Buy 6,000 $0.83 $5.0K 143,542
Sell 167,149 $3.15 $526.1K 11,273,364 −1.5% of holding
Sell 80,783 $3.11 $250.9K 11,440,513 −0.7% of holding
Sell 42,129 $3.11 $131.2K 11,521,296 −0.4% of holding
Lantheus Holdings, Inc. 10% Owner Sell 35,769 $3.12 $111.6K 11,563,425 −0.3% of holding
Lantheus Alpha Therapy, LLC 10% Owner Sell 35,769 $3.12 $111.6K 11,563,425 −0.3% of holding
Lantheus Holdings, Inc. 10% Owner Sell 78,145 $3.14 $245.6K 11,599,194 −0.7% of holding
Lantheus Alpha Therapy, LLC 10% Owner Sell 78,145 $3.14 $245.6K 11,599,194 −0.7% of holding

Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.